TechInvention ties up with Eubiologics to launch oral cholera vaccine

TechInvention ties up with Eubiologics to launch oral cholera vaccine

TechInvention Lifecare India has joined hands with biopharmaceutical company Eubiologics, South Korea, to launch Euvichol-Plus, a cost-effective oral cholera vaccine available in low density polyethylene (LDPE) unidose pack.

Euvichol-Plus is prequalified by World Health Organisation and is available in around twenty-two countries globally. The LDPE unidose pack is easy and safe to use, and also reduces the issues pertaining to conventional glass vials in terms of breakage, storage, transportation and wastage management.

As per WHO reports, cholera has around three percent mortality rate, especially among young children. India, being the second most populous country in the world suffers the maximum economic burden of cholera with the situation further worsening during disease outbreaks which frequently occurs in many states.

Limited availability of the jab, pose a great risk making thousands of children succumb to cholera which can be effectively prevented by a vaccine. It is estimated that around 83 million doses of cholera vaccine will be required in India by 2025.

In this context, TechInvention’ Founder & CEO, Mr Syed Ahmed said, “It is our endeavour to bring in a WHO Pre Qualified OCV in India for managing potential outbreak risk caused due to the often-neglected disease like cholera. We wish to play our part in supporting Indian Govt’ & WHO’s initiative of  ‘Ending Cholera- Global Roadmap by 2030’, by offering affordable, easy to use, safe & efficacious vaccine”.